Company Overview - TriSalus Life Sciences is a mission-driven company focused on enhancing drug delivery to pancreatic, liver, and solid tumors [3] - The company is developing nelitolimod, an immunotherapeutic aimed at reversing immunosuppression in tumors, with the goal of improving patient outcomes for those suffering from serious cancers [3] Event Highlights - The inaugural webinar features discussions on uterine fibroids embolization, presented by distinguished physicians Dr. Nicole Lamparello and Dr. Francis Kang, highlighting it as a preferable alternative to surgery for patients with uterine fibroids [2] - The event aims to illustrate the value of TriSalus's technology in addressing significant medical challenges [2]